Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin - Wikidata - wikimedia - TriplyDB

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

http://www.wikidata.org/entity/Q35175999

about

Silencing of CXCR4 and CXCR7 expression by RNA interference suppresses human endometrial carcinoma growth in vivo Quantification of cellular viability by automated microscopy and flow cytometry Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics.CXCR4 knockdown inhibits the growth and invasion of nasopharyngeal cancer stem cells.Silencing RIF1 decreases cell growth, migration and increases cisplatin sensitivity of human cervical cancer cells.

P2860

Q33623183-E16BAADE-84B5-48C9-B573-8E16E885270E Q35588918-FE869028-5A74-49FB-A74F-A3E74F0C397A Q36208362-21F0B858-959D-4F00-9883-98D4031A09EB Q37685449-FA4DEF3D-C392-4EE4-9604-7F25992BF590 Q38845317-C34AC8BD-BD84-4B7A-8708-4831C616FE1A Q39002027-F6F6DFFD-B417-45B3-AB13-C6FBA8EC1333 Q39433258-406C8040-BD1C-467C-A9A6-F7169C91DE5D Q42033255-F9D98B6C-0F1A-48D6-B2F4-4B6171775EE3 Q47146406-488E3F54-0A33-4414-9696-E22724FD10D8

P2860

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

http://www.wikidata.org/entity/Q35175999

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

@ast

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

@en

type

label

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

@ast

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

@en

prefLabel

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

@ast

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

@en

P1433

Q35175999-0799711E-A7D2-4B97-B02E-5D74EA8F9DED

P1476

Q35175999-4D460981-B7C2-4350-8A82-DA2D81C20E9C

P2093

Q35175999-2669F89E-D803-45A6-BF1C-72FD9CFAA343

Q35175999-36C4F502-7FDB-47F5-B3E1-D85F767CCD90

Q35175999-53E16906-A26F-4E7C-B405-B5F22B10CC5C

Q35175999-73B69C7C-C76A-4352-B028-54AC9E7BBBBA

Q35175999-96700B35-1C52-47C8-BC4F-E60ACE2AD6D8

Q35175999-BB0CDF77-198A-4A3F-8D04-9F4B3A0471B9

Q35175999-BD59EF29-7130-4C2E-8465-13121F3A1129

Q35175999-FC1910D2-4359-48AA-96F2-59E7CF36E4C3

P2860

Q35175999-18638C53-6D79-4FA0-8320-292C70DB5137

Q35175999-1A63DE32-9563-4931-92D6-C3E8D6FE6305

Q35175999-232B7D98-DCC1-4B92-B5B6-4168658F02F6

Q35175999-24817523-AE61-4A46-8D2F-618C3B80A096

Q35175999-25A4F5E1-4476-4E68-BEC6-C06FB41D4D4A

Q35175999-2A1F1930-2165-400D-83C7-B98873CCAC43

Q35175999-2C65091A-EF76-4A9C-927C-57DC8D5422AC

Q35175999-319B3F2E-4DEE-42B9-B447-C8B7541A4C6C

Q35175999-322F47C3-BF0C-4518-BF99-F8E379989D2C

Q35175999-32AA1646-BA9D-459A-ADC2-2734160BF13A

P304

Q35175999-1F76502E-06EC-461E-BD30-D3A3BA09D65F

P31

Q35175999-35866193-394F-4186-B92C-ED3891B6E869

P356

Q35175999-2B689CDC-E306-4C09-BB49-27BA9DFFA1A9

P407

Q35175999-6F21BC07-7C5E-41F8-B753-908B66A15524

P433

Q35175999-30BFCFF8-88D4-4D02-B6D8-6B91D036EAC8

P478

Q35175999-3E1D7C9F-9123-44A2-9100-224A97B55054

P577

Q35175999-E9B8C331-47B6-42D0-B1E2-27E826D52471

P5875

Q35175999-90483E06-FAD7-4F97-88E4-0B45BA7201B5

P698

Q35175999-0DD79103-9F11-4831-94C1-16DD288F9E23

P932

Q35175999-A2548371-6575-48F4-A785-FC1876186A69

P356

ONCOTARGET.2741

P1433

P1476

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

@en

P2093

Caiwen Du

http://www.w3.org/2001/XMLSchema#string

Guojun Zhang

http://www.w3.org/2001/XMLSchema#string

Linhao Xie

http://www.w3.org/2001/XMLSchema#string

Ping Yang

http://www.w3.org/2001/XMLSchema#string

Sixian Liang

http://www.w3.org/2001/XMLSchema#string

Xiaoli Li

http://www.w3.org/2001/XMLSchema#string

Xun Peng

http://www.w3.org/2001/XMLSchema#string

Yaochen Li

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting triple-negative breast cancer: optimising therapeutic outcomes

Surfing the p53 network

Triple-Negative Breast Cancer

Preclinical perspectives on platinum resistance.

Interplay between Mdm2 and HIPK2 in the DNA damage response.

CXCL12 (SDF-1)/CXCR4 pathway in cancer.

Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer.

Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin

Targeting cell death in tumors by activating caspases.

Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.

P304

1020-1030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2741

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270292168

http://www.w3.org/2001/XMLSchema#string

P698

25544759

http://www.w3.org/2001/XMLSchema#string

P932

4359214

http://www.w3.org/2001/XMLSchema#string